nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—Venous thrombosis—Carboplatin—uterine cancer	0.0294	0.0729	CcSEcCtD
Dihydroxyaluminium—VDAC3—myometrium—uterine cancer	0.0258	0.0444	CbGeAlD
Dihydroxyaluminium—Fluid overload—Carboplatin—uterine cancer	0.0255	0.0633	CcSEcCtD
Dihydroxyaluminium—VDAC1—myometrium—uterine cancer	0.0246	0.0422	CbGeAlD
Dihydroxyaluminium—VDAC2—epithelium—uterine cancer	0.0243	0.0418	CbGeAlD
Dihydroxyaluminium—VDAC2—uterine cervix—uterine cancer	0.0241	0.0415	CbGeAlD
Dihydroxyaluminium—VDAC2—renal system—uterine cancer	0.0226	0.0388	CbGeAlD
Dihydroxyaluminium—VDAC2—uterus—uterine cancer	0.0201	0.0346	CbGeAlD
Dihydroxyaluminium—VDAC3—uterine cervix—uterine cancer	0.0201	0.0345	CbGeAlD
Dihydroxyaluminium—VDAC3—smooth muscle tissue—uterine cancer	0.0195	0.0336	CbGeAlD
Dihydroxyaluminium—VDAC1—epithelium—uterine cancer	0.0193	0.0331	CbGeAlD
Dihydroxyaluminium—VDAC3—decidua—uterine cancer	0.0191	0.0329	CbGeAlD
Dihydroxyaluminium—VDAC1—uterine cervix—uterine cancer	0.0191	0.0329	CbGeAlD
Dihydroxyaluminium—VDAC3—renal system—uterine cancer	0.0188	0.0323	CbGeAlD
Dihydroxyaluminium—VDAC1—smooth muscle tissue—uterine cancer	0.0186	0.0319	CbGeAlD
Dihydroxyaluminium—VDAC1—decidua—uterine cancer	0.0182	0.0313	CbGeAlD
Dihydroxyaluminium—Extravasation—Carboplatin—uterine cancer	0.0182	0.0451	CcSEcCtD
Dihydroxyaluminium—VDAC3—endometrium—uterine cancer	0.0182	0.0312	CbGeAlD
Dihydroxyaluminium—VDAC2—female reproductive system—uterine cancer	0.0181	0.0311	CbGeAlD
Dihydroxyaluminium—VDAC1—renal system—uterine cancer	0.0179	0.0307	CbGeAlD
Dihydroxyaluminium—VDAC3—mammalian vulva—uterine cancer	0.0176	0.0302	CbGeAlD
Dihydroxyaluminium—VDAC1—endometrium—uterine cancer	0.0173	0.0297	CbGeAlD
Dihydroxyaluminium—VDAC3—uterus—uterine cancer	0.0167	0.0288	CbGeAlD
Dihydroxyaluminium—VDAC1—mammalian vulva—uterine cancer	0.0167	0.0287	CbGeAlD
Dihydroxyaluminium—VDAC2—female gonad—uterine cancer	0.0164	0.0283	CbGeAlD
Dihydroxyaluminium—VDAC1—uterus—uterine cancer	0.0159	0.0274	CbGeAlD
Dihydroxyaluminium—VDAC1—Levonorgestrel—Progesterone—uterine cancer	0.0152	1	CbGdCrCtD
Dihydroxyaluminium—VDAC3—female reproductive system—uterine cancer	0.0151	0.0259	CbGeAlD
Dihydroxyaluminium—TNNC1—endometrium—uterine cancer	0.0148	0.0255	CbGeAlD
Dihydroxyaluminium—VDAC1—female reproductive system—uterine cancer	0.0143	0.0246	CbGeAlD
Dihydroxyaluminium—Venous thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.014	0.0347	CcSEcCtD
Dihydroxyaluminium—VDAC3—female gonad—uterine cancer	0.0137	0.0236	CbGeAlD
Dihydroxyaluminium—VDAC3—vagina—uterine cancer	0.0136	0.0234	CbGeAlD
Dihydroxyaluminium—Phlebitis—Carboplatin—uterine cancer	0.0134	0.0332	CcSEcCtD
Dihydroxyaluminium—VDAC1—female gonad—uterine cancer	0.013	0.0224	CbGeAlD
Dihydroxyaluminium—VDAC1—vagina—uterine cancer	0.0129	0.0223	CbGeAlD
Dihydroxyaluminium—VDAC2—lymph node—uterine cancer	0.0106	0.0182	CbGeAlD
Dihydroxyaluminium—VDAC3—lymph node—uterine cancer	0.0088	0.0151	CbGeAlD
Dihydroxyaluminium—VDAC1—lymph node—uterine cancer	0.00837	0.0144	CbGeAlD
Dihydroxyaluminium—Lightheadedness—Progesterone—uterine cancer	0.00746	0.0185	CcSEcCtD
Dihydroxyaluminium—TNNC1—lymph node—uterine cancer	0.00718	0.0123	CbGeAlD
Dihydroxyaluminium—Thrombophlebitis—Progesterone—uterine cancer	0.00699	0.0173	CcSEcCtD
Dihydroxyaluminium—Extravasation—Dactinomycin—uterine cancer	0.00676	0.0168	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Progesterone—uterine cancer	0.00639	0.0158	CcSEcCtD
Dihydroxyaluminium—Thirst—Progesterone—uterine cancer	0.00636	0.0158	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00634	0.0157	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00579	0.0144	CcSEcCtD
Dihydroxyaluminium—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00576	0.0143	CcSEcCtD
Dihydroxyaluminium—Infection—Carboplatin—uterine cancer	0.00563	0.014	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00522	0.0129	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Progesterone—uterine cancer	0.0051	0.0126	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Dactinomycin—uterine cancer	0.00497	0.0123	CcSEcCtD
Dihydroxyaluminium—Extravasation—Etoposide—uterine cancer	0.00489	0.0121	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Etoposide—uterine cancer	0.00486	0.012	CcSEcCtD
Dihydroxyaluminium—Pain—Carboplatin—uterine cancer	0.00484	0.012	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Carboplatin—uterine cancer	0.00448	0.0111	CcSEcCtD
Dihydroxyaluminium—Venous thrombosis—Epirubicin—uterine cancer	0.00443	0.011	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Progesterone—uterine cancer	0.0042	0.0104	CcSEcCtD
Dihydroxyaluminium—Venous thrombosis—Doxorubicin—uterine cancer	0.0041	0.0102	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Progesterone—uterine cancer	0.00404	0.01	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00366	0.00907	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Etoposide—uterine cancer	0.00359	0.00891	CcSEcCtD
Dihydroxyaluminium—Back pain—Progesterone—uterine cancer	0.00353	0.00874	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Progesterone—uterine cancer	0.00344	0.00852	CcSEcCtD
Dihydroxyaluminium—Chills—Medroxyprogesterone Acetate—uterine cancer	0.0034	0.00844	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Epirubicin—uterine cancer	0.00338	0.00838	CcSEcCtD
Dihydroxyaluminium—Vertigo—Progesterone—uterine cancer	0.00328	0.00812	CcSEcCtD
Dihydroxyaluminium—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.0032	0.00792	CcSEcCtD
Dihydroxyaluminium—Convulsion—Progesterone—uterine cancer	0.00316	0.00783	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Doxorubicin—uterine cancer	0.00313	0.00775	CcSEcCtD
Dihydroxyaluminium—Oedema—Progesterone—uterine cancer	0.00298	0.00738	CcSEcCtD
Dihydroxyaluminium—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00297	0.00736	CcSEcCtD
Dihydroxyaluminium—Infection—Progesterone—uterine cancer	0.00296	0.00733	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Progesterone—uterine cancer	0.0029	0.0072	CcSEcCtD
Dihydroxyaluminium—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.0071	CcSEcCtD
Dihydroxyaluminium—Hypotension—Progesterone—uterine cancer	0.00278	0.00689	CcSEcCtD
Dihydroxyaluminium—Extravasation—Epirubicin—uterine cancer	0.00274	0.0068	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Epirubicin—uterine cancer	0.00272	0.00675	CcSEcCtD
Dihydroxyaluminium—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.00668	CcSEcCtD
Dihydroxyaluminium—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00268	0.00664	CcSEcCtD
Dihydroxyaluminium—Chills—Dactinomycin—uterine cancer	0.00266	0.00659	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00263	0.00652	CcSEcCtD
Dihydroxyaluminium—Pain—Progesterone—uterine cancer	0.00254	0.00631	CcSEcCtD
Dihydroxyaluminium—Extravasation—Doxorubicin—uterine cancer	0.00254	0.00629	CcSEcCtD
Dihydroxyaluminium—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00625	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00252	0.00624	CcSEcCtD
Dihydroxyaluminium—Urticaria—Progesterone—uterine cancer	0.00236	0.00586	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Progesterone—uterine cancer	0.00235	0.00583	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Epirubicin—uterine cancer	0.00232	0.00576	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Progesterone—uterine cancer	0.00219	0.00544	CcSEcCtD
Dihydroxyaluminium—Coma—Epirubicin—uterine cancer	0.00219	0.00542	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00215	0.00533	CcSEcCtD
Dihydroxyaluminium—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.00531	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00528	CcSEcCtD
Dihydroxyaluminium—Oedema—Dactinomycin—uterine cancer	0.0021	0.00521	CcSEcCtD
Dihydroxyaluminium—Infection—Dactinomycin—uterine cancer	0.00209	0.00518	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Progesterone—uterine cancer	0.00204	0.00505	CcSEcCtD
Dihydroxyaluminium—Coma—Doxorubicin—uterine cancer	0.00202	0.00501	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Epirubicin—uterine cancer	0.00201	0.005	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Epirubicin—uterine cancer	0.00201	0.00497	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00493	CcSEcCtD
Dihydroxyaluminium—Dizziness—Progesterone—uterine cancer	0.00197	0.00488	CcSEcCtD
Dihydroxyaluminium—Chills—Etoposide—uterine cancer	0.00192	0.00477	CcSEcCtD
Dihydroxyaluminium—Vomiting—Progesterone—uterine cancer	0.00189	0.00469	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Doxorubicin—uterine cancer	0.00186	0.00462	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Doxorubicin—uterine cancer	0.00186	0.0046	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00457	CcSEcCtD
Dihydroxyaluminium—Back pain—Etoposide—uterine cancer	0.0018	0.00447	CcSEcCtD
Dihydroxyaluminium—Pain—Dactinomycin—uterine cancer	0.0018	0.00446	CcSEcCtD
Dihydroxyaluminium—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00442	CcSEcCtD
Dihydroxyaluminium—Nausea—Progesterone—uterine cancer	0.00177	0.00438	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Epirubicin—uterine cancer	0.00174	0.00432	CcSEcCtD
Dihydroxyaluminium—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00425	CcSEcCtD
Dihydroxyaluminium—Vertigo—Etoposide—uterine cancer	0.00168	0.00415	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Dactinomycin—uterine cancer	0.00166	0.00412	CcSEcCtD
Dihydroxyaluminium—Convulsion—Etoposide—uterine cancer	0.00162	0.00401	CcSEcCtD
Dihydroxyaluminium—Dehydration—Epirubicin—uterine cancer	0.00161	0.004	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Doxorubicin—uterine cancer	0.00161	0.004	CcSEcCtD
Dihydroxyaluminium—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00397	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Dactinomycin—uterine cancer	0.00155	0.00384	CcSEcCtD
Dihydroxyaluminium—Infection—Etoposide—uterine cancer	0.00151	0.00375	CcSEcCtD
Dihydroxyaluminium—Dehydration—Doxorubicin—uterine cancer	0.00149	0.0037	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Etoposide—uterine cancer	0.00149	0.00368	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Epirubicin—uterine cancer	0.00146	0.00362	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dactinomycin—uterine cancer	0.00144	0.00357	CcSEcCtD
Dihydroxyaluminium—Hypotension—Etoposide—uterine cancer	0.00142	0.00353	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Doxorubicin—uterine cancer	0.00135	0.00335	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dactinomycin—uterine cancer	0.00134	0.00332	CcSEcCtD
Dihydroxyaluminium—Pain—Etoposide—uterine cancer	0.0013	0.00323	CcSEcCtD
Dihydroxyaluminium—Nausea—Dactinomycin—uterine cancer	0.00125	0.0031	CcSEcCtD
Dihydroxyaluminium—Urticaria—Etoposide—uterine cancer	0.00121	0.003	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Epirubicin—uterine cancer	0.0012	0.00298	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Etoposide—uterine cancer	0.0012	0.00298	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Epirubicin—uterine cancer	0.00116	0.00287	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Etoposide—uterine cancer	0.00112	0.00278	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Doxorubicin—uterine cancer	0.00111	0.00276	CcSEcCtD
Dihydroxyaluminium—Chills—Epirubicin—uterine cancer	0.00108	0.00267	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Doxorubicin—uterine cancer	0.00107	0.00265	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Etoposide—uterine cancer	0.00104	0.00258	CcSEcCtD
Dihydroxyaluminium—Back pain—Epirubicin—uterine cancer	0.00101	0.00251	CcSEcCtD
Dihydroxyaluminium—Dizziness—Etoposide—uterine cancer	0.00101	0.0025	CcSEcCtD
Dihydroxyaluminium—Chills—Doxorubicin—uterine cancer	0.000997	0.00247	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Epirubicin—uterine cancer	0.000985	0.00244	CcSEcCtD
Dihydroxyaluminium—Vomiting—Etoposide—uterine cancer	0.000968	0.0024	CcSEcCtD
Dihydroxyaluminium—Vertigo—Epirubicin—uterine cancer	0.000939	0.00233	CcSEcCtD
Dihydroxyaluminium—Back pain—Doxorubicin—uterine cancer	0.000936	0.00232	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Doxorubicin—uterine cancer	0.000912	0.00226	CcSEcCtD
Dihydroxyaluminium—Convulsion—Epirubicin—uterine cancer	0.000906	0.00225	CcSEcCtD
Dihydroxyaluminium—Nausea—Etoposide—uterine cancer	0.000904	0.00224	CcSEcCtD
Dihydroxyaluminium—Vertigo—Doxorubicin—uterine cancer	0.000869	0.00215	CcSEcCtD
Dihydroxyaluminium—Oedema—Epirubicin—uterine cancer	0.000853	0.00212	CcSEcCtD
Dihydroxyaluminium—Infection—Epirubicin—uterine cancer	0.000848	0.0021	CcSEcCtD
Dihydroxyaluminium—Convulsion—Doxorubicin—uterine cancer	0.000838	0.00208	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Epirubicin—uterine cancer	0.000833	0.00206	CcSEcCtD
Dihydroxyaluminium—Hypotension—Epirubicin—uterine cancer	0.000797	0.00198	CcSEcCtD
Dihydroxyaluminium—Oedema—Doxorubicin—uterine cancer	0.000789	0.00196	CcSEcCtD
Dihydroxyaluminium—Infection—Doxorubicin—uterine cancer	0.000784	0.00194	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Doxorubicin—uterine cancer	0.00077	0.00191	CcSEcCtD
Dihydroxyaluminium—Hypotension—Doxorubicin—uterine cancer	0.000738	0.00183	CcSEcCtD
Dihydroxyaluminium—Pain—Epirubicin—uterine cancer	0.00073	0.00181	CcSEcCtD
Dihydroxyaluminium—Urticaria—Epirubicin—uterine cancer	0.000678	0.00168	CcSEcCtD
Dihydroxyaluminium—Pain—Doxorubicin—uterine cancer	0.000675	0.00167	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Epirubicin—uterine cancer	0.000674	0.00167	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Epirubicin—uterine cancer	0.000629	0.00156	CcSEcCtD
Dihydroxyaluminium—Urticaria—Doxorubicin—uterine cancer	0.000627	0.00155	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Doxorubicin—uterine cancer	0.000624	0.00155	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Epirubicin—uterine cancer	0.000584	0.00145	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Doxorubicin—uterine cancer	0.000582	0.00144	CcSEcCtD
Dihydroxyaluminium—Dizziness—Epirubicin—uterine cancer	0.000564	0.0014	CcSEcCtD
Dihydroxyaluminium—Vomiting—Epirubicin—uterine cancer	0.000542	0.00134	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Doxorubicin—uterine cancer	0.00054	0.00134	CcSEcCtD
Dihydroxyaluminium—Dizziness—Doxorubicin—uterine cancer	0.000522	0.00129	CcSEcCtD
Dihydroxyaluminium—Nausea—Epirubicin—uterine cancer	0.000507	0.00126	CcSEcCtD
Dihydroxyaluminium—Vomiting—Doxorubicin—uterine cancer	0.000502	0.00124	CcSEcCtD
Dihydroxyaluminium—Nausea—Doxorubicin—uterine cancer	0.000469	0.00116	CcSEcCtD
